Patent intelligence · US
US 9410913
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
Patent details — US 9410913
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 9, 2016
- Expiration
- Aug 4, 2036
- Applicant
- Aytu BioScience, Inc.
- Claims
- 4
- CPC classes
- A61K, A61K35/16
Quick answer
US 9410913 (Methods and systems for measuring and using the oxidation-reduction potential of a biological sample) is held by Aytu BioScience, Inc.. Status: granted. Granted Aug 9, 2016. Expires Aug 4, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aytu BioScience, Inc.
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K35/16
More from Aytu BioScience, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11534474
Oral compositions for bladder regulation and uses thereof
granted -
US 10184931
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted -
US 9360446
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted
Frequently asked questions
What is US patent 9410913?
US 9410913 (Methods and systems for measuring and using the oxidation-reduction potential of a biological sample) is held by Aytu BioScience, Inc.. Status: granted. Granted Aug 9, 2016. Expires Aug 4, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9410913?
Aytu BioScience, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 9410913 expire?
Our index shows an expiration date of Aug 4, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.